- Home
- CMCM vs FBRX Comparison
CMCM vs FBRX Comparison
Compare CMCM & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCM | FBRX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.2M | 170.0M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMCM | FBRX |
|---|---|---|
| Price | $6.80 | $19.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 41.8K | ★ 112.6K |
| Earning Date | 11-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $151,517,306.00 | N/A |
| Revenue This Year | $14.27 | N/A |
| Revenue Next Year | $39.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 46.34 | N/A |
| 52 Week Low | $3.28 | $4.90 |
| 52 Week High | $9.44 | $28.68 |
Technical Indicators
Market Signals| Indicator | CMCM | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 63.00 |
| Support Level | $7.26 | $17.35 |
| Resistance Level | $9.00 | $22.61 |
| Average True Range (ATR) | 0.65 | 2.01 |
| MACD | 0.07 | 0.21 |
| Stochastic Oscillator | 21.15 | 61.72 |
Price Performance
Historical ComparisonAbout CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).